Eun kyung Choi
Daegu, Korea (the Republic Of), 41944, South Korea
NCT Number: NCT03933605
In the present study, midazolam and palonosetron in combination were more effective than palonosetron alone in lowering the incidence and severity of postoperative nausea and vomiting in the initial 2 h after laparoscopic cholecystectomy. Postoperative clinical complications were not different in both groups.
Looking for future studies?
Notify Me20 year–65 year
Female
Interventional
Not applicable
Daegu, Korea (the Republic Of), 41944, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
intravenous midazolam and palonosetron administraion as prevention of postoperative nausea and vomiting
intravenous palonosetron administraion as prevention of postoperative nausea and vomiting
Time frame: 24 hours after surgery
0=none; 1=occur
Time frame: 24 hours after surgery
0 = absent; 1 = mild; 2 = moderate; 3 = severe
Yeungnam University College of Medicine
Other
Comparison of Palonosetron With Combined Palonosetron and Midazolam for Preventing Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03712891
Behavior, Health Behavior
Cincinnati, Ohio, United States
View Trial DetailsNCT05618236
Confusion, Delirium
Istanbul, Maltepe, Turkey (Türkiye)
View Trial DetailsNCT04466579
Confusion, Delirium
Ostrava, Moravian-Silesian Region, Czechia
View Trial DetailsNCT04260659
Body Weight, Nausea
Warsaw, Poland
View Trial Details